No Impact of Pre-existing Cardiovascular Disease on Prescribing Patterns of Sulphonylureas in Denmark - A Registry-based Nationwide Study
出版年份 2018 全文链接
标题
No Impact of Pre-existing Cardiovascular Disease on Prescribing Patterns of Sulphonylureas in Denmark - A Registry-based Nationwide Study
作者
关键词
-
出版物
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume 122, Issue 6, Pages 606-611
出版商
Wiley
发表日期
2018-01-12
DOI
10.1111/bcpt.12961
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Approach to diabetes management in patients with CVD
- (2016) Sanam Lathief et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
- (2016) Jens Sundbøll et al. BMJ Open
- Guideline adherence and health outcomes in diabetes mellitus type 2 patients: a cross-sectional study
- (2015) Sandra F Oude Wesselink et al. BMC HEALTH SERVICES RESEARCH
- Sulfonylurea Prescribing Patterns After the Introduction of DPP-4 Inhibitors and GLP-1 Receptor Agonists
- (2015) Stephanie L. Payk et al. CLINICAL THERAPEUTICS
- Adherence to NICE guidance on glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes mellitus: an evaluation using the Clinical Practice Research Datalink
- (2015) Kevin Jameson et al. CURRENT MEDICAL RESEARCH AND OPINION
- Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer
- (2015) A. S. Abdelmoneim et al. DIABETES OBESITY & METABOLISM
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY – CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN – 2015
- (2015) Yehuda Handelsman et al. Endocrine Practice
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
- (2015) Jennifer B. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- An update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerations
- (2015) Barbara Kornek Patient Preference and Adherence
- Mortality risk among sulfonylureas: a systematic review and network meta-analysis
- (2015) Scot H Simpson et al. Lancet Diabetes & Endocrinology
- The Danish National Patient Registry: a review of content, data quality, and research potential
- (2015) Morten Schmidt et al. Clinical Epidemiology
- Diabetes management in the real world and the impact of adherence to guideline recommendations
- (2014) Jean Lian et al. CURRENT MEDICAL RESEARCH AND OPINION
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
- (2014) Silvio E. Inzucchi et al. DIABETES CARE
- Combination therapy with metformin plus sulphonylureas versus metformin plus DPP-4 inhibitors: association with major adverse cardiovascular events and all-cause mortality
- (2014) C. Ll. Morgan et al. DIABETES OBESITY & METABOLISM
- Cardiovascular safety of combination therapies with incretin-based drugs and metformin compared with a combination of metformin and sulphonylurea in type 2 diabetes mellitus - a retrospective nationwide study
- (2014) U. M. Mogensen et al. DIABETES OBESITY & METABOLISM
- Metformin usage in type 2 diabetes mellitus: are safety guidelines adhered to?
- (2014) W. Huang et al. INTERNAL MEDICINE JOURNAL
- Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
- (2014) Rury R Holman et al. LANCET
- The use of clinical guidelines highlights ongoing educational gaps in physicians’ knowledge and decision making related to diabetes
- (2014) Mark D Corriere et al. BMC Medical Education
- Guidelines adherence in the treatment of patients with newly diagnosed type 2 diabetes: a historical cohort comparing the use of metformin in Quebec pre and post-Canadian Diabetes Association guidelines
- (2013) Ting-Yu Wang et al. BMC HEALTH SERVICES RESEARCH
- Ambulatory Treatment of Type 2 Diabetes in the U.S., 1997–2012
- (2013) Lydia W. Turner et al. DIABETES CARE
- Rosiglitazone use and post-discontinuation glycaemic control in two European countries, 2000–2010
- (2013) V Ehrenstein et al. BMJ Open
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETOLOGIA
- Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study
- (2011) Tina Ken Schramm et al. EUROPEAN HEART JOURNAL
- Antidiabetic treatments and risk of hospitalisation with myocardial infarction: a nationwide case-control study
- (2011) Henriette Thisted Horsdal et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The Danish National Patient Register
- (2011) Elsebeth Lynge et al. SCANDINAVIAN JOURNAL OF PUBLIC HEALTH
- Comparison of two sulfonylureas with high and low myocardial KATP channel affinity on myocardial infarct size and metabolism in a rat model of type 2 diabetes
- (2010) S. B. Kristiansen et al. DIABETOLOGIA
- Responding to an FDA Warning — Geographic Variation in the Use of Rosiglitazone
- (2010) Nilay D. Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends in All-Cause and Cardiovascular Disease Mortality Among Women and Men With and Without Diabetes Mellitus in the Framingham Heart Study, 1950 to 2005
- (2009) Sarah Rosner Preis et al. CIRCULATION
- Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study
- (2009) Henriette T. Horsdal et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started